SCHEMBL28515327

SCHEMBL28515327

Cc1cc(F)cc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 8/20 1.00
FGFR1 P11362 4/20 1.00
ABL1 P00519 2/20 0.55
PDGFRB P09619 1/20 0.55
KIT P10721 1/20 0.55
SRC P12931 1/20 0.55
BRAF P15056 1/20 0.55
KDR P35968 1/20 0.55
EPHB4 P54760 1/20 0.55
TEK Q02763 1/20 0.55
LCK P06239 5/20 0.53
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
TP53 P04637 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ERBB3 P21860 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL374328 0.85 EGFR (0.74) EGFRFGFR1ABL1PDGFRBKIT
SCHEMBL379004 0.80 EGFR (0.69) EGFRFGFR1ABL1PDGFRBKIT
SCHEMBL28261624 0.80 EGFR (1.00) EGFRFGFR1ABL1PDGFRBKIT
SCHEMBL374014 0.78 EGFR (0.66) EGFRFGFR1ABL1PDGFRBKIT
SCHEMBL28503748 0.78 EGFR (0.66) EGFRFGFR1ABL1PDGFRBKIT
SCHEMBL28514560 0.78 EGFR (0.64) EGFRFGFR1ABL1PDGFRBKIT
SCHEMBL374526 0.75 EGFR (0.69) EGFRFGFR1ABL1PDGFRBKIT
SCHEMBL374173 0.75 EGFR (0.75) EGFRFGFR1ABL1PDGFRBKIT
SCHEMBL377191 0.74 EGFR (0.61) EGFRFGFR1ABL1PDGFRBKIT
SCHEMBL28516203 0.74 EGFR (0.61) EGFRFGFR1ABL1PDGFRBKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109053593-B 1- (2, 6-chlorphenyl) -3- (substituted pyrimidine-4-yl) urea compound and preparation and application thereof 温州医科大学 2020-12-04 CN disclosed